21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC
McKesson McKesson

Agency partners

Intertrade Ireland Intertrade Ireland
IDA Ireland IDA Ireland

Day 1 Plenary session

12:00
Delegate registration and networking lunch
13:00
Mary Dickens, President, Irish Pharmaceutical Healthcare Association and Country Chair & General Manager of General Medicines, Sanofi Ireland
Welcome address
Session 1: Ambition for medical and biopharma innovation
13:05


13:20


13:50


14:20
- Martin Shanahan, Chief Executive Officer, IDA Ireland
Opening address

- David L. Chesney, Principal and General Manager, DL Chesney Consulting, LLC
Adapting “current” GMP to innovative technologies – A challenge for regulators

- Dr Lorraine Nolan, Chief Executive, Health Products Regulatory Authority (HPRA)
European regulation for the 21st Century – the path forward

Panel discussion
14:50
Networking break
Session 2: The future for genomics and advanced therapeutics
Chaired by Dr Darrin Morrissey, Director of Programmes, Science Foundation Ireland
15:15


16:00


16:20



16:40


17:00
- Sean Ennis, Chief Scientific Officer and Founder, Genomics Medicine Ireland
Building a genetic atlas of the Irish population & The promise of precision medicine

- Dr Steven Elmore, Ph.D. Vice President Target Enabling Science & Technology, Discovery Research AbbVie
Harnessing the Power of Human Genetics for Better Therapies – are we there yet?

- Dr Louise Jopling, Senior Director Immunology Science, Johnson & Johnson Innovation and
- Prof Colin Hill, Professor of Microbiology, University College Cork
How bacterial viruses can change medicine as we know it

- Dr John Murphy, Vice President, Biology, Rare Disease Research Unit, Pfizer
Gene Therapy at Pfizer: Where we are, where we are going and what we are learning along the way

Panel discussion


Close